Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam

Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients

(2017) Krisztina M. Papp-Wallace et al.   ACS Infectious Diseases

Exploring the role of the Ω-loop in the evolution of ceftazidime resistance in the PenA β-lactamase from Burkholderia multivorans , an important Cystic Fibrosis pathogen

(2016) Krisztina M. Papp-Wallace et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibiotic resistance in Burkholderia species

(2016) Katherine A. Rhodes et al.   DRUG RESISTANCE UPDATES

Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases

(2013) David E. Ehmann et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Insights into β-Lactamases fromBurkholderiaSpecies, Two Phylogenetically Related yet Distinct Resistance Determinants

(2013) Krisztina M. Papp-Wallace et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Extreme Antimicrobial Peptide and Polymyxin B Resistance in the Genus Burkholderia

(2011) Slade A. Loutet et al.   Frontiers in Microbiology

In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters

(2010) S. Mushtaq et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Naturally Occurring Class A ss-Lactamases from the Burkholderia cepacia Complex

(2008) L. Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY